Telangana Heatwave Crisis 16 Deaths Trigger 4 Lakh ExGratia Economic Impact Under Scrutiny Viatris Inc Analysts Weigh PostMerger Strategy and Generic Drug Portfolio Outlook AI Economy Reshapes Job Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Roles Slow Germany Resists EU Pressure for Tougher China Stance as Trade Minister Visits Beijing The Rise of HALO Stocks Investing in What Artificial Intelligence Cannot Replace KKR Co Examining Its LongTerm Potential in a Dynamic Market SOWG Q3 2025 Earnings Significant EPS Miss Overshadows Quarter PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines Novagold Resources Inc NG Q1 2026 Earnings EPS Exceeds Estimates as Company Maintains Focus on Donlin Gold Project LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances USEA Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by 116 PMTW Q1 2026 Earnings Significant EPS Miss Despite Modest Share Gains MicroVision MVIS Surges 477 as Stock Tests Key Resistance Zone Provident Financial Services PFS Advances 17 as It Approaches Key Resistance Calumet Inc CLMT Edges Lower Amid Consolidation Key Support and Resistance in Focus Manulife Financial MFC Holds Steady at 3869 as Bulls Eye Resistance MoonLake Immunotherapeutics MLTX Holds Near Support as Biotech Sector Sends Mixed Signals Sensex Nifty Wobble as Mixed Session Unfolds Hind Zinc SBI Force Motors Lead Activity First Financial Bancorp FFBC Q1 2026 Earnings Earnings Beat Expectations as Core Operations Hold Steady Alamo Group Inc ALG Climbs 163 as Shares Test Key Resistance Near 160 Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline BWIN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress INMD Q1 2026 Earnings EPS Misses Estimates as Company Faces Headwinds ArrowMark Financial Corp BANX Q4 2022 Earnings EPS Misses Estimates Stock Slips Slightly Gentherm Inc THRM Q1 2026 Earnings EPS Crushes Estimates Stock Rises NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 ABTC Q1 2026 Earnings Deep EPS Miss Highlights Operational Challenges